| 000 | 01288nam a2200337 i 4500 | ||
|---|---|---|---|
| 005 | 20250919011706.0 | ||
| 008 | 160405 2014 nyua 000 0 eng d | ||
| 020 |
_a9781633214033 _cRM695.97 |
||
| 039 | 9 |
_a201606291250 _bazriq _c201606291247 _dazriq _c201606241556 _dafifah _c201606131629 _dbalqis _y04-05-2016 _zsalmah |
|
| 040 |
_aUKM _erda |
||
| 090 | _aWI700.H529p 2014 9HUKM | ||
| 090 |
_aWI700 _b.H529p 2014 9HUKM |
||
| 245 | 0 | 0 |
_aHepatic steatosis : _bclinical risk factors, molecular mechanisms and treatment outcomes / _cedited by Sergio Santos. |
| 264 | 4 |
_aNew York : _bNova Science Publishers, _c[2014], ©2014. |
|
| 300 |
_avii, 271 pages : _billustrations ; _c26 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 490 | 1 | _aHepatology research and clinical developments | |
| 500 | _aIncludes index. | ||
| 650 | 2 | _aLiver diseases. | |
| 700 | 1 |
_aSantos, Sergio, _eeditor. |
|
| 830 | 0 | _aHepatology research and clinical developments. | |
| 907 |
_a.b16300920 _b2022-09-02 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kWI700.H529p 2014 9HUKM |
||
| 914 | _avtls003603461 | ||
| 990 | _aSalmah/azriq/Nazmi. | ||
| 991 | _aJabatan Perubatan, PPUKM. | ||
| 998 |
_ah _b2016-05-04 _cm _da _feng _gnyu _y0 _z.b16300920 |
||
| 999 |
_c607648 _d607648 |
||